GLP-1 receptors, including semaglutide, are effective for managing the triad of obesity, diabetes, and cancer
160 SayinV
Semaglutide led to a significant reduction in HbA1c levels compared to placebo- Patients receiving semaglutide experienced significant weight loss compared to those on placebo PIONEER Trials (Peptide Innovation for Early Diabetes Treatment): The PIONEER (Peptide Innovation for Early Diabetes Treatment) trials were a series of global, randomized, controlled clinical trials that investigated the efficacy, safety, and tolerability of oral semaglutide, a GLP-1 receptor agonist, in patients with type 2 diabetes
I will tell you, in the phase three trials, anywhere from 8 to 15% of individuals in the trials so we know they're taking the drug do not lose at least 5% of their body weight
You can also look into the Low Income Subsidy (LIS)/Extra Help program and see if you are eligible
Resetting habits like understanding your relationship with food, managing hunger and cravings, and sticking to your plan, is crucial for long-term success